Dentons advised the offeror - Korporacja Inwestycyjna Polskiej Farmacji sp. z o.o. - with regard to the tender offer for sale of 100% shares in Pelion S.A. The offeror is a company controlled by Mr. Jacek Szwajcowski, with Mr. Zbigniew Molenda holding a minority stake. Messrs. Szwajcowski and Molenda are both founders of Pelion. The tender offer is addressed to other shareholders of Pelion S.A.

It is the largest tender offer for shares of a company listed on the Warsaw Stock Exchange this year.

The Pelion group consists of ca. 170 subsidiaries. Services provided by the group encompass all market sectors (wholesale, retail and the hospital market) and are addressed to patients, pharmacies, hospitals and manufacturers.  Pelion S.A. is a holding company exercising ownership supervision over all areas of the business of the Group, implemented accordingly by Polska Grupa Farmaceutyczna SA - wholesale, PGF Urtica - supplies for hospitals, CEPD N.V - retail sale and Pharmalink - services for manufacturers.

The Dentons team assisting the transaction was headed by Jakub Celinski, partner of Dentons Warsaw acting in cooperation with Michal Mezykowski (partner), Ryszard Manteuffel and Piotr Nerwinski (senior associates) and Lee Federman, partner of Dentons London.